Equitable Trust CO Bristol Myers Squibb CO Transaction History

Equitable Trust CO

$1.47 Billion
Q3 2024

A detailed history of Equitable Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Equitable Trust CO holds 21,890 shares of BMY stock, worth $1.26 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

21,890

Previous 24,056 9.0%

Holding current value

$1.26 Million

Previous $999,000 13.31%

% of portfolio

0.08%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $85,903 - $112,090	-2,166 Reduced 9.0%	21,890 $1.13 Million
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $14,288 - $18,811	355 Added 1.5%	24,056 $999,000
Q1 2024 Apr 25, 2024	SELL	$47.98 - $54.4 $312,829 - $354,688	-6,520 Reduced 21.57%	23,701 $1.29 Million
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $29,427 - $35,114	-607 Reduced 1.97%	30,221 $1.55 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $68,020 - $76,057	-1,175 Reduced 3.67%	30,828 $1.79 Million
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $128,331 - $145,557	-1,953 Reduced 5.75%	32,003 $2.22 Million
Q4 2022 Feb 21, 2023	SELL	$68.48 - $81.09 $226,531 - $268,245	-3,308 Reduced 8.88%	33,956 $2.44 Million
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $182 - $107,576	1,400 Added 3.9%	37,264 $2.65 Million
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $14,524 - $15,996	200 Added 0.56%	35,864 $2.76 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $205,527 - $246,445	3,343 Added 10.34%	35,664 $2.6 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $21,452 - $25,008	400 Added 1.25%	32,321 $2.02 Million
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $72,424 - $84,835	-1,224 Reduced 3.69%	31,921 $1.89 Million
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $292,524 - $318,559	-4,725 Reduced 12.48%	33,145 $2.22 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $52,278 - $58,797	881 Added 2.38%	37,870 $2.39 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $60,511 - $68,570	1,048 Added 2.92%	36,989 $2.29 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $21,708 - $24,055	-378 Reduced 1.04%	35,941 $2.17 Million
Q2 2020 Aug 18, 2020	BUY	$54.82 - $64.09 $66,661 - $77,933	1,216 Added 3.46%	36,319 $2.14 Million
Q1 2020 May 21, 2020	BUY	$46.4 - $67.43 $129,920 - $188,804	2,800 Added 8.67%	35,103 $1.96 Million
Q4 2019 Feb 18, 2020	SELL	$49.21 - $64.19 $110,624 - $144,299	-2,248 Reduced 6.51%	32,303 $2.07 Million
Q3 2019 Nov 19, 2019	SELL	$42.77 - $50.71 $75,061 - $88,996	-1,755 Reduced 4.83%	34,551 $1.75 Million
Q2 2019 Aug 16, 2019	SELL	$44.62 - $49.34 $40,559 - $44,850	-909 Reduced 2.44%	36,306 $1.65 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $25,222 - $30,074	559 Added 1.52%	37,215 $1.78 Million
Q4 2018 Feb 22, 2019	SELL	$48.76 - $63.23 $101,664 - $131,834	-2,085 Reduced 5.38%	36,656 $1.91 Million
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $17,384 - $19,608	-315 Reduced 0.81%	38,741 $2.41 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $1.97 Million - $2.46 Million	39,056 New	39,056 $2.16 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Bristol Myers Squibb CO Transaction History